Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Shares Outstanding (Weighted Average): 2010-2024

Historic Shares Outstanding (Weighted Average) for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $1.9 million.

  • China Pharma Holdings' Shares Outstanding (Weighted Average) rose 90.06% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 90.06%. This contributed to the annual value of $1.9 million for FY2024, which is 192.15% up from last year.
  • As of FY2024, China Pharma Holdings' Shares Outstanding (Weighted Average) stood at $1.9 million, which was up 192.15% from $659,033 recorded in FY2023.
  • China Pharma Holdings' 5-year Shares Outstanding (Weighted Average) high stood at $1.9 million for FY2024, and its period low was $87,159 during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $895,885, with a median of $659,033 in 2023.
  • Data for China Pharma Holdings' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 538.07% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows China Pharma Holdings' Shares Outstanding (Weighted Average) stood at $87,159 in 2020, then increased by 8.63% to $94,679 in 2021, then rose by 9.09% to $103,285 in 2022, then skyrocketed by 538.07% to $659,033 in 2023, then spiked by 192.15% to $1.9 million in 2024.